Announced Wed, 6 May · 14:44 IST

Newspaper Publication for standalone Audited financial results for the quarter and financial year ended on 31st March, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.3%1-day move
₹1079.90
prior close
₹1152.25
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2-0.4+0.4+8.3+7.8+6.4+7.1+9.0+11.1+6.9+7.4+2.0
Up moveDown movePending
AI summary

Jenburkt Pharmaceuticals Ltd has filed a notification that its standalone audited financial results for Q4 FY26 and full financial year ended 31st March 2026 were published in two newspapers on 6th May 2026. The Board of Directors had approved these results at their meeting held on 5th May 2026. The company states that the full financial results are available on BSE and the company's website. The actual financial figures and numbers are not included in this filing - only the notification of their publication.

Likely market impact

This is a routine regulatory filing confirming that annual and quarterly financial results have been officially disclosed to the public. The actual financial performance data would be available in a separate detailed filing, and investors should refer to that for specific numbers on revenue, profit, and other metrics.